Skip to content

Jay S Stout, Chief Technology Officer at Immunovant, sold IMVT on Jul 8, 2026

Data as of Oct 16

▼ SELL$55.3K1,399 shares at $39.53Jay S Stout Chief Technology OfficerIMVT Immunovant, Inc.
Watch IMVT
Traded
Jul 8, 2026
Disclosed
Jul 10, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jay S Stout, Chief Technology Officer at Immunovant, sold IMVT on Jul 8, 2026TRADEDDISCLOSED
IMVTSimilar stocks (XLV — its sector index fund), rebased to IMVT's price on the disclosure day
IMVT since disclosure
−32.7%
after the sale
Similar stocks (XLV) since disclosure
+9.9%
XLV — its sector index fund

Change in closing price from Jul 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJay S Stout Chief Technology OfficerIMVT Immunovant, Inc.$75.3Kdisclosed Jul 10 · filed 2 days after the trade
  2. ▼ SELLJay S Stout Chief Technology OfficerIMVT Immunovant, Inc.$4.2Kdisclosed Jul 10 · filed 2 days after the trade
  3. ▼ SELLJay S Stout Chief Technology OfficerIMVT Immunovant, Inc.$3.1Kdisclosed Jul 10 · filed 2 days after the trade

See every trade on IMVT →